title: CDKN2A and MC1R mutations in patients with sporadic multiple primary melanoma.
authors.forename: Ketty
authors.initials: K
authors.lastname: Peris
authors.forename: Maria Concetta
authors.initials: MC
authors.lastname: Fargnoli
authors.forename: Alessia
authors.initials: A
authors.lastname: Pacifico
authors.forename: Tiziana
authors.initials: T
authors.lastname: Surrenti
authors.forename: Wilhem
authors.initials: W
authors.lastname: Stolz
authors.forename: Peter
authors.initials: P
authors.lastname: Wolf
authors.forename: Hans Peter
authors.initials: HP
authors.lastname: Soyer
authors.forename: Sergio
authors.initials: S
authors.lastname: Chimenti
mesh_terms: D000328:Adult; D000368:Aged; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000235:genetics*; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000235:genetics*; D011979:Receptors, Pituitary Hormone / Q000235:genetics*; D012878:Skin Neoplasms / Q000235:genetics*
chemical_list: D019941:Cyclin-Dependent Kinase Inhibitor p16; D011979:Receptors, Pituitary Hormone; C029446:MSH receptor